Temporal trends in rates of prostate cancer: declining incidence of advanced stage disease, 1974 to 1994.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Journal of Urology

• Publication date

  1997-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0022-5347(01)64231-9PMID 9302136
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cancer statistics, 1997

  1997cited by this paper
• Trends in prostate carcinoma incidence in Connecticut (1988–1994) by age and race

  1997cited by this paper
• Qui doit nourrir l'enfant de parents non mariés ou démariés ? : La charge de l'enfant

  1997cited by this paper
• The fall in incidence of prostate carcinoma: On the down side of a prostate specific antigen induced peak in incidence‐‐Data from the Utah Cancer Registry

  1996cited by this paper
• Rapid rise and subsequent decline in prostate cancer incidence rates for New Mexico, 1989-1993.

  1995cited by this paper
• The role of increasing detection in the rising incidence of prostate cancer.

  1995cited by this paper
• Prostate cancer: trends in mortality and stage-specific incidence rates by racial/ethnic group in Los Angeles County, California (United States)

  1995cited by this paper
• Changes in prostate cancer incidence and treatment in USA.

  1994cited by this paper
• An assessment of radical prostatectomy. Time trends, geographic variation, and outcomes. The Prostate Patient Outcomes Research Team.

  1993cited by this paper
• Purification of a human prostate specific antigen.

  1979cited by this paper

• From blue November to broader diagnosis: The Youden index to evaluate the performance of any diagnostic tests

  2025cites this paper
• Hemoglobin-Albumin-Lymphocyte-Platelet (HALP) Score as a Predictive Value of Incidental Prostate Cancer for Patients Going for Transurethral Resection of the Prostate (TURP): A Single-Center Study

  2024cites this paper
• Evaluation of the Prognostic Role of TP53 Gene Mutations in Prostate Cancer Outcome: A Systematic Review and Meta-Analysis.

  2024cites this paper
• A Novel Blood Proteomic Signature for Prostate Cancer

  2023cites this paper
• microRNA-205 in prostate cancer: Overview to clinical translation.

  2022cites this paper
• Prevalence of multimorbidity in men of African descent with and without prostate cancer in Soweto, South Africa

  2022cites this paper
• Association Between Periodontal Disease and Risk of Prostate Cancer in a Greek Adult Population : A Case - Control Study

  2022cites this paper
• A cellular senescence-related gene prognostic index for biochemical recurrence and drug resistance in patients with prostate cancer.

  2022cites this paper
• The Etiology of Prostate Cancer

  2021cites this paper
• Acute toxicity and patient‐reported symptom score after conventional versus moderately hypofractionated proton therapy for prostate cancer

  2021cites this paper
• Prostate cancer in Saudi Arabia: trends in incidence, morphological and epidemiological characteristics

  2020cites this paper
• Superior survival benefits of Radical Prostatectomy than External Beam Radiotherapy in aging 75 and older men with high-risk or very high-risk Prostate Cancer: a population-matched study

  2020cites this paper
• Special emphasis on bone health management in prostate cancer patients: a prospective longitudinal study

  2020cites this paper
• A different perspective: Can urine pH be important in the diagnosis of prostate cancer?

  2019cites this paper
• Detection of a prostate cancer cell line using a bioluminescent affiprobe: An attempt to develop a new molecular probe for ex vivo studies.

  2019cites this paper
• Prostate cancer and the role of biomarkers

  2019cites this paper
• The Alteration of Life Quality Between Hormone Treatment-Receiving and Non-Receiving Early-Stage Prostate Cancer Patients Who Underwent Radiotherapy

  2018cites this paper
• Testiranje na PSA u ranom otkrivanju karcinoma prostate

  2018cites this paper
• Gleason’s Grading of Carcinoma Prostate with PSA Correlation

  2017cites this paper
• Prostate Cancer and the Evolving Role of Biomarkers in Screening and Diagnosis.

  2017cites this paper
• Triple Positive Microparticles as a “Liquid Biopsy” for Risk Stratification of Prostate Cancer

  2017cites this paper
• Abiraterone Acetate for Treatment of Metastatic Castration‐resistant Prostate Cancer in Chemotherapy‐naive Patients: An Italian Analysis of Patients' Satisfaction

  2017cites this paper
• General practitioner perception of prostate-specific antigen testing has improved, but more awareness of prostate cancer risk in younger patients is still awaited

  2017cites this paper
• Quality of Life Outcomes after Primary Treatment for Clinically Localised Prostate Cancer: A Systematic Review.

  2017cites this paper
• Complexity of Prostate Cancer Diagnosis in African American Men in the United States

  2016cites this paper
• Is there any association between National Institute of Health category IV prostatitis and prostate-specific antigen levels in patients with low-risk localized prostate cancer?

  2016cites this paper
• Prostate cancer in men aged less than 50 years at diagnosis

  2016cites this paper
• Hospital Charity Care--Effects of New Community-Benefit Requirements.

  2015cites this paper
• Prostate cancer cell-derived exosomes enable androgen production by patients derived stem cells: Exploring racial disparity and targeting residual androgen through stem cell-based selective delivery of 3alpha-HSD

  2015cites this paper
• Multi-parametric magnetic resonance imaging in the diagnosis of prostate cancer

  2015cites this paper
• Trends in Metastatic Breast and Prostate Cancer--Lessons in Cancer Dynamics.

  2015cites this paper
• The uptake of active surveillance for the treatment of prostate cancer in Ontario: Results of a population-based study

  2015cites this paper
• Current status of magnetic resonance imaging (MRI) and ultrasonography fusion software platforms for guidance of prostate biopsies

  2014cites this paper
• Functional and oncological outcomes of patients aged <50 years treated with radical prostatectomy for localised prostate cancer in a European population

  2014cites this paper
• An early-detection programme for prostate cancer in Saudi men: A call from a tertiary-care centre in the Eastern province

  2014cites this paper
• CÁNCER DE PRÓSTATA LOCALIZADO TRATADO CON CIRUGÍA RADICAL. EXPERIENCIA DE UN CENTRO.

  2014cites this paper
• Epidemiology of Prostate Cancer

  2013cites this paper
• Course of the type of patient who is candidate for radical prostatectomy over 2 decades (1989-2009).

  2013cites this paper
• Comparative analysis of prostate cancer specific biomarkers in whole urine, urinary sediments and exosomes

  2013cites this paper
• Gleason 6 prostate tumors diagnosed in the PSA era do not demonstrate the capacity for metastatic spread at the time of radical prostatectomy.

  2013cites this paper
• Reaction Assay for Human Glandular Kallikrein Variant-specific Reverse Transcriptase-Polymerase Chain Detection of Metastatic Prostate Cancer Using a Splice

  2013cites this paper
• Evolución del tipo de paciente candidato a prostatectomía radical a lo largo de 2 décadas (1989-2009)

  2013cites this paper
• UNIVERZITA PALACKÉHO V OLOMOUCI

  2013cites this paper
• HIV and Prostate Cancer

  2013cites this paper
• Study of Incidence of Carcinoma Prostate in Central India With Reference To Gleason's grading

  2013cites this paper
• Prostate cancer in younger and older patients: do we treat them differently?

  2012cites this paper
• LHRH Agonists for the Treatment of Prostate Cancer: 2012.

  2012cites this paper
• El antígeno prostático específico (PSA): Biología y utilidad en el despistaje del cáncer de próstata

  2012cites this paper
• Improvement in Prostate Cancer Survival Over Time: A 20-Year Analysis

  2012cites this paper
• MicroRNAs as Prognostic Biomarkers in Prostate Cancer

  2012cites this paper
• Epidemiology, Etiology, and Prevention of Prostate Cancer

  2012cites this paper
• Temporal changes in the clinical approach to diagnosing prostate cancer.

  2012cites this paper
• ProstateCancerinYoungerandOlderPatients:DoWeTreat Them Differently?

  2012cites this paper
• Prostate Cancer Postoperative Nomogram Scores and Obesity

  2011cites this paper
• An evidence review of active surveillance in men with localized prostate cancer.

  2011cites this paper
• Prostate Cancer Staging and Grading at Radical Prostatectomy Over Time

  2011cites this paper
• Prostate specific antigen velocity per prostate volume: a novel tool for prostate biopsy prediction.

  2011cites this paper
• Titration of Dosage for the Protective Effect of Zoledronic Acid on Bone Loss in Patients Submitted to Androgen Deprivation Therapy due to Prostate Cancer: A Prospective Open-Label Study

  2010cites this paper
• Management of prostate cancer in HIV-positive patients

  2010cites this paper
• Recent time trends in the epidemiology of stage IV prostate cancer in the United States: analysis of data from the Surveillance, Epidemiology, and End Results Program.

  2010cites this paper
• Lebensqualität nach radikaler Prostatovesikulektomie in Abhängigkeit vom intraoperativen Erhalt des Gefäß-Nerven-Bündels

  2009cites this paper
• Improving Intermittent Androgen-Deprivation Therapy: OFF Cycle and the Role of Steroid 5α-Reductase Inhibitors

  2009cites this paper
• Changes in Prostate Cancer Pattern according to Prostate-Specific Antigen Screening Test

  2009cites this paper
• Prostate Carcinoma: Introduction

  2009cites this paper
• Apocrine sweat gland obstruction by antiperspirants allowing transdermal absorption of cutaneous generated hormones and pheromones as a link to the observed incidence rates of breast and prostate cancer in the 20th century.

  2009cites this paper
• Prostate cancer in elderly men.

  2008cites this paper
• Impact of body mass index on biochemical recurrence rates after radical prostatectomy: an analysis utilizing propensity score matching.

  2008cites this paper
• Histopathological findings in extended prostate biopsy with PSA < or = 4 ng/mL.

  2008cites this paper
• Perception of abnormal serum prostate-specific antigen (PSA) test results amongst family practitioners.

  2008cites this paper
• Long-term prediction of prostate cancer: prostate-specific antigen (PSA) velocity is predictive but does not improve the predictive accuracy of a single PSA measurement 15 years or more before cancer diagnosis in a large, representative, unscreened population.

  2008cites this paper
• Biomarkers and Risk Factors Impact of Body Mass Index on Biochemical Recurrence Rates After Radical Prostatectomy: An Analysis Utilizing Propensity Score Matching

  2008cites this paper
• Aberrationen von Chromosom 8p im Prostatakarzinom: Von Gendosis- über Expressionsveränderungen zu neuen Kandidatengenen

  2008cites this paper
• Information Seeking and Satisfaction With Physician–Patient Communication Among Prostate Cancer Survivors

  2008cites this paper
• Cáncer de próstata en el paciente de edad avanzada

  2007cites this paper
• Diagnosis of prostate cancer.

  2007cites this paper
• Adenopatías mediastínicas en la evolución de un cáncer de próstata metastásico

  2007cites this paper
• The impact of definitions of failure on the interpretation of biochemical recurrence following treatment of clinically localized prostate cancer.

  2007cites this paper
• Epidemiology of prostate cancer.

  2007cites this paper
• [Mediastinal lymph nodes during the course of a metastatic prostate cancer].

  2007cites this paper
• Impact of patient age on biochemical recurrence rates following radical prostatectomy.

  2007cites this paper
• Cancer in older men: A gender-based review

  2006cites this paper
• [Prostate cancer in the elderly patient].

  2006cites this paper
• The Usefulness of the Critical Pathway for Radical Retropubic Prostatectomy

  2006cites this paper
• Cancer de la prostate du sujet âgé

  2006cites this paper
• The increased rate of prostate specific antigen testing has not affected prostate cancer presentation in an inner city population in the UK

  2006cites this paper
• Inadequacies of the current American Joint Committee on cancer staging system for prostate cancer

  2006cites this paper
• A discussion of general prostate cancer screening versus targeted diagnosis in younger men

  2005cites this paper
• Current Status of Prostate Screening

  2005cites this paper
• Prostate specific antigen as a clinical biomarker for prostate cancer: What’s the take home message?

  2005cites this paper
• Screening for prostate cancer in military populations.

  2005cites this paper
• A review of surgical techniques for radical prostatectomy.

  2005cites this paper
• Migrations in clinical and pathological stage of prostatic carcinoma in patients undergoing radical prostatectomy in the period between 1993 and 2003.

  2005cites this paper
• Use of PSA to Evaluate Risk and Progression of Prostate Cancer

  2005cites this paper
• Population-based prostate cancer trends in the United States: patterns of change in the era of prostate-specific antigen

  2005influential citation
• Inhibition of prostate cancer metastatic colonization by ∼4.2 Mb of human chromosome 12

  2004cites this paper
• Defining an Optimum PSA-Based Screening Strategy for Young Men

  2004cites this paper
• Prostate cancer in the ageing male

  2004cites this paper
• More favorable tumor features and progression-free survival rates in a longitudinal prostate cancer screening study: PSA era and threshold-specific effects.

  2004cites this paper
• Patterns of secondary cancer treatment for biochemical failure following radical prostatectomy: data from CaPSURE.

  2004cites this paper
• Do younger men have better biochemical outcomes after radical prostatectomy?

  2004cites this paper